| Prev Close | 88.72 |
| Open | 88.60 |
| Day Low/High | 88.51 / 89.53 |
| 52 Wk Low/High | 70.89 / 89.53 |
| Volume | 8.27M |
| Avg Volume | 8.30M |
Merck & Co. Inc. (MRK)
89.10
0.38
0.43
NYSE : Health Technology
| Exchange | NYSE |
| Shares Outstanding | 2.55B |
| Market Cap | 225.88B |
| EPS | 2.30 |
| P/E Ratio | 41.65 |
| Div & Yield | 2.44 (2.48%) |
Closing Bell: LIVE MARKETS BLOG
It was a down day across the board on Wall Street.
Cramer: We're Seeing the Best of Times and the Worst of Times at the Same Time
It depends on which aisle of the stock market you're on.
Which Way Are These Stocks Going?
Finding bullish and bearish reversals in the market.
Merck's Price Strength Is Ailing
Even if the stock bounces, an advance is unlikely.
Midday Update: Stocks Mixed as Healthcare Struggles, Tech Continues Gains
Stocks were mixed at midday Monday as Merck weighed on the Dow and tech strength boosted the Nasdaq.
3 Small-Caps on My Growth Stock Radar
LGI Homes, ANI Pharmaceuticals and Sonus Networks are worth considering.
Stop Worrying About Valuations After Amazon, Alphabet and Microsoft's Earnings
The revenue and profit gains from some of the biggest technology companies like Amazon AMZN, Alphabet GOOGL and Microsoft MSFT show that valuations aren't so stretched.
There Is Sound Fundamental Reasoning Behind the Positivity: Market Recon
The ECB's super dovish message was good for the markets.
Alphabet, Amazon and Expedia: This Is What You Must Know on Friday
U.S. futures point a higher open following earnings beats from Amazon, Alphabet and Microsoft after the bell on Thursday.
Cramer: What's Tax Reform Got to Do With It?
Treasury secretary says it's baked into the market, but is anyone really counting on it?
KalVista Shares Skyrocket On Merck Collaboration, Ovid Pops -- Biotech Movers
Cambridge, Mass.-based KalVista Pharmaceuticals on Oct. 10 unveiled a collaboration pact with Merck.
Positive Signs in Drug Distribution
Blockbuster drugs still need companies to deliver them.
Intermediate Trade: Merck & Co
Try this bearishly biased, in-the-money vertical put spread on MRK.
Cramer: Got the Apple-FANG Blues? Look for a Rotation
There's one going on now.
'Date' These Potential Biotech Winners
As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.
'Date' These Potential Biotech Winners
As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.
Cramer: August Finally Arrives
There are plenty of reasons for the selloff, not the least of which is White House chaos.
President Trump Has Disbanded His Manufacturing Council
Pressure is mounting on CEOs to step down from President Donald Trump's American Manufacturing Council
CEOs Dump Donald Trump
CEOs exit President's Council after Charlottesville response
Daily Market Preview: CEOs Dump Trump & Activists Stir the Danone Pot
CEOs exit President's Council after Charlottesville response
North Korea Dials Down Tensions With United States, Stocks Higher
North Korea says it will delay a decision on attacking Guam.
Rev's Forum: Bears' Fundamental Arguments Lose Out to Price Patterns
The problem for the pessimists is the same one that has plagued them since the election -- the price action is not cooperating.
Cramer: This Is Why You Keep Cash on Hand
Because the selloff isn't over.
President Trump Condemns Hate Groups, Days After Charlottesville Attack
Days after the deadly attack in Charlottesville, President Trump comes out with his strongest condemnation yet of the hate groups who rallied there.
Jim Cramer on Merck, Bitcoin, Nvidia, Netflix, Disney, Procter & Gamble, TJX and Home Depot
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer analyzes Monday's trending stocks.
Jim Cramer on Merck CEO Ken Frazier: Everyone Has a Right to Speak Their Mind
Merck CEO Ken Frazier is leaving Trump's business council.
Cramer: FANG and the Lessons of History
What a difference 2 years make -- or 17.
Merck Is Benefiting From Keytruda, but Jim Cramer Prefers Eli Lilly
Merck vs. Eli Lilly.
Jim Cramer on Amazon, Tesla, Starbucks, Exxon, Chevron, American Airlines, Southwest Airlines, Merck and Tax Reform
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Friday's trending stocks.
Does Merck's Rally Have Legs?
MRK has shaped up on the charts.
